Nuvalent (NUVL) Cash from Financing Activities (2020 - 2026)

Nuvalent (NUVL) reported Cash from Financing Activities of $9.8 million for Q1 2026, up 115.5% on a YoY basis from $4.5 million in Q1 2025, and down 98.04% quarter-over-quarter from $500.3 million in Q4 2025.

Nuvalent (NUVL) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Nuvalent has reported Cash from Financing Activities for 7 years, with the latest figure at $9.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 115.5% year-over-year to $9.8 million; the trailing twelve-month figure through Mar 2026 stood at $520.6 million (down 8.26% YoY), and the FY2025 full-year result was $515.3 million, down 9.41% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $9.8 million, down from $500.3 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $550.3 million in Q3 2024, with the low at -$768000.0 in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $98.8 million across 5 years, with a median of $4.8 million in 2025.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 107.68% — and 2024, when it jumped 35311.76%.
  • Nuvalent's Cash from Financing Activities stood at $248.7 million in 2022, then jumped by 34.08% to $333.4 million in 2023, then plunged by 97.45% to $8.5 million in 2024, then surged by 5791.0% to $500.3 million in 2025, then sank by 98.04% to $9.8 million in 2026.
  • The last three Cash from Financing Activities figures came in at $9.8 million (Q1 2026), $500.3 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 7.00 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 53,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - 85,464.43
10 Nuvalent 9.70 Bn 9.70 Bn - 9.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.80 Mn
Mar 31, 2026 9.80 Mn
Dec 31, 2025 500.26 Mn
Dec 31, 2025 500.26 Mn
Sep 30, 2025 4.77 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 5.76 Mn
Jun 30, 2025 5.76 Mn
Mar 31, 2025 4.55 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 8.49 Mn
Dec 31, 2024 8.49 Mn
Sep 30, 2024 550.27 Mn
Sep 30, 2024 550.27 Mn
Jun 30, 2024 4.14 Mn
Jun 30, 2024 4.14 Mn
Mar 31, 2024 5.99 Mn
Mar 31, 2024 5.99 Mn
Dec 31, 2023 333.42 Mn
Dec 31, 2023 333.42 Mn